JFrog Ltd. FROG 深 沪
等待开盘 04-02 09:30:00 美东时间
48.46
+1.530
+3.26%
华盛通- 最 高49.64
- 今 开47.56
- 成交量 326.21万股
- 最 低 46.75
- 昨 收 46.93
- 总市值 57.97亿
- 52周最高 70.4299
- 市盈率 静 --
- 换手率 2.73%
- 52周最低 29.50
- 委 比 -2.18%
- 总股本 1.20亿
- 历史最高 95.20
- 量 比 0.92
- 振 幅 6.16%
- 历史最低 16.356
- 每 手 1
- 风险率 9.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AAR Foods Posts Upbeat Q3 Earnings, Joins Braze, Arm Holdings And Other Big Stocks Moving Higher On Wednesday
U.S. stocks rose, with the Dow Jones gaining 350 points on Wednesday. AAR Corp (NYSE: AIR) saw a 10.5% jump in shares after reporting strong earnings and raising its sales forecast.
03-26 02:32
美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级
今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元
03-25 10:31
UBS Upgrades JFrog to Buy, Announces $60 Price Target
UBS analyst Radi Sultan upgrades JFrog (NASDAQ:FROG) from Neutral to Buy and announces $60 price target.
03-24 20:20
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
Guggenheim Initiates Coverage On JFrog with Buy Rating, Announces Price Target of $60
Guggenheim analyst Howard Ma initiates coverage on JFrog (NASDAQ:FROG) with a Buy rating and announces Price Target of $60.
03-16 19:38
JFrog shares are trading higher after the company announced a $300 million share repurchase program.
JFrog shares are trading higher after the company announced a $300 million shar...
02-27 00:28
JFrog Board Authorizes $300M Share Repurchase Program
JFrog Ltd. ("JFrog") (NASDAQ:FROG), the Liquid Software company and creators of the JFrog Software Supply Chain Platform, today announced that its Board of Directors has authorized a share repurchase program of up to
02-26 22:16
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
JFrog to Present at Morgan Stanley, Raymond James, and Cantor Investor Conferences
JFrog to Present at Morgan Stanley, Raymond James, and Cantor Investor Conferences JFrog Ltd. will present at three investor conferences in the first quarter of 2026: the Morgan Stanley Technology, Media & Telecom Conference in San Francisco on March 2, 2026; the Raymond James Institutional Investor
02-24 05:06
Stifel Maintains Buy on JFrog, Lowers Price Target to $52
Stifel analyst Brad Reback maintains JFrog (NASDAQ:FROG) with a Buy and lowers the price target from $64 to $52.
02-23 23:17
